Olaparib in Combination With Pembrolizumab for Advanced Uveal Melanoma
Conditions: Uveal Melanoma; Ocular Melanoma Interventions: Drug: Pembrolizumab; Drug: Olaparib Sponsors: H. Lee Moffitt Cancer Center and Research Institute; Merck Sharp & Dohme LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 1, 2022 Category: Research Source Type: clinical trials
Adjuvant Melatonin for Uveal Melanoma
Conditions: Uveal Melanoma; Uveal Melanoma, Posterior, Medium/Large Size; Eye Cancer, Intraocular Melanoma Intervention: Drug: Melatonin Sponsors: Gustav Stalhammar; Karolinska Trial Alliance; Swedish Cancer Society; The Swedish Eye Foundation (Ögonfonden); The Swedish Society of Medicine Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2022 Category: Research Source Type: clinical trials